BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28508063)

  • 1. The long noncoding RNA
    Lee B; Sahoo A; Marchica J; Holzhauser E; Chen X; Li JL; Seki T; Govindarajan SS; Markey FB; Batish M; Lokhande SJ; Zhang S; Ray A; Perera RJ
    Sci Adv; 2017 May; 3(5):e1602505. PubMed ID: 28508063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA
    Lee B; Katsushima K; Pokhrel R; Yuan M; Stapleton S; Jallo G; Wechsler-Reya RJ; Eberhart CG; Ray A; Perera RJ
    Neurooncol Adv; 2022; 4(1):vdac120. PubMed ID: 36267874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes.
    Zhao W; Mazar J; Lee B; Sawada J; Li JL; Shelley J; Govindarajan S; Towler D; Mattick JS; Komatsu M; Dinger ME; Perera RJ
    J Invest Dermatol; 2016 Apr; 136(4):819-828. PubMed ID: 26829028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network.
    Morelli E; Gulla' A; Amodio N; Taiana E; Neri A; Fulciniti M; Munshi NC
    Methods Mol Biol; 2021; 2348():189-204. PubMed ID: 34160808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis.
    Wakefield N; Rajan R; Sontheimer EJ
    FEBS Lett; 2015 Oct; 589(20 Pt B):3197-204. PubMed ID: 26364721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cellular mRNAs translation by CRISPR-Cas9.
    Liu Y; Chen Z; He A; Zhan Y; Li J; Liu L; Wu H; Zhuang C; Lin J; Zhang Q; Huang W
    Sci Rep; 2016 Jul; 6():29652. PubMed ID: 27405721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Xist silencing domain by Tiling CRISPR.
    Wang Y; Zhong Y; Zhou Y; Tanaseichuk O; Li Z; Zhao JC
    Sci Rep; 2019 Feb; 9(1):2408. PubMed ID: 30787302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art technologies to explore long non-coding RNAs in cancer.
    Salehi S; Taheri MN; Azarpira N; Zare A; Behzad-Behbahani A
    J Cell Mol Med; 2017 Dec; 21(12):3120-3140. PubMed ID: 28631377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR.
    Rankin CR; Treger J; Faure-Kumar E; Benhammou J; Anisman-Posner D; Bollinger AE; Pothoulakis C; Padua DM
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30882798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-CasRx knock-in mice for RNA degradation.
    Li J; Zhu D; Hu S; Nie Y
    Sci China Life Sci; 2022 Nov; 65(11):2248-2256. PubMed ID: 35412223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
    Song M
    Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evx1/Evx1as gene locus regulates anterior-posterior patterning during gastrulation.
    Bell CC; Amaral PP; Kalsbeek A; Magor GW; Gillinder KR; Tangermann P; di Lisio L; Cheetham SW; Gruhl F; Frith J; Tallack MR; Ru KL; Crawford J; Mattick JS; Dinger ME; Perkins AC
    Sci Rep; 2016 May; 6():26657. PubMed ID: 27226347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.